<DOC>
	<DOCNO>NCT01471145</DOCNO>
	<brief_summary>The aim project study brain function 20 heroin addict ( compare brain function 20 healthy control ) three month extend release naltrexone treatment use functional MRI dopamine transporter SPECT . The following hypothesis test : - XRNT modulate fMRI response drug cue predetermine brain region . - The expression striatal transporter ( assessed SPECT ) decrease three-month course extend release naltrexone</brief_summary>
	<brief_title>Depot Naltrexone Mechanism Action Heroin Dependent Patients Using fMRI SPECT</brief_title>
	<detailed_description>Heroin dependence quintessential international health problem , significant prevalence . Drug free treatment , include pharmacologically support intervention use oral naltrexone , successful , mainly due low compliance . The recent introduction Vivitrol® , consist monthly injection , may create new opportunity . Vivitrol® innovative treatment delivery method block reward effect heroin .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Heroin dependent patient : diagnosis opioid dependence accord DSMIV criterion , heroin primary drug abuse inhalation primary route administration . Healthy control : diagnosis substance dependence , current psychotropic medication . Care take match control gender , age , smoke status , IQ handedness . Age 18 55 Medical contraindication XRNT MRI ( Langleben 2006 ; Langleben , Ruparel et al . 2008 ) . Briefly , former include candidate know hypersensitivity naltrexone , PLG ( polylactidecoglycolide ) , carboxymethylcellulose , component Vivitrol® diluent , hepatic renal disease , chronic pain syndrome , female subject pregnant lactating , child bear potential use acceptable method birth control . MRI contraindication include chronic medical ( neurological , cardiovascular , infectious , metabolic , etc ) condition may affect brain morphology and/or activity indwell foreign metallic magnetically sensitive object device , shrapnel , pacemaker , orthopaedic fixation device vascular stent Presence disorder preclude normal perception visual auditory stimulus , color blindness , deafness , severe myopia , etc . Patients history current psychosis current major depressive disorder suicidal ideation Patients treat forced treatment condition History evidence disorder may affect cerebral function circulation , diabetes metabolic disorder , encephalopathy , cardiovascular cerebrovascular disease , history head trauma depress skull fracture prolong loss consciousness history brain surgery Female subject : woman pregnant breastfeed Current psychotropic medication Use prescription medication could affect alertness circulatory system IQ &lt; 70 Naltrexone use within past 6 month Baseline aspartate aminotransferase alanine aminotransferase three time upper limit normal Patients intention opioidfree minimum 7 day start XRNT treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>heroin dependence</keyword>
	<keyword>extended release depot naltrexone</keyword>
	<keyword>functional Magnetic Resonance Imaging</keyword>
	<keyword>dopamine transporter</keyword>
	<keyword>Single Photon Emission Computed Tomography</keyword>
</DOC>